Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Impact of itopride on functional dyspepsia symptom progression: a multicenter noninterventional postregistration study
Jiri Dolina, Jan Tack, Serhiy Forostyak, et al.
International Journal of Molecular Sciences
|
August 27, 2021
Neuropharmacology of Cevimeline and Muscarinic Drugs-Focus on Cognition and Neurodegeneration
Patrik Oleksak, Michal Novotny, Jiri Patocka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 11, 2023
The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease
Martin Valis, Alzbeta Dlabkova, Jakub Hort, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 29, 2023
Corrigendum to "The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease" [Biomed. Pharmacother. 159 (2023) 114223]
Martin Valis, Alzbeta Dlabkova, Jakub Hort, et al.
European Neurology
|
July 20, 2023
Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis
Marek Peterka, Martin Valis, Ondrej Soucek, et al.
Frontiers in Public Health
|
January 23, 2024
Pregabalin use in forensic hospitals and prisons in German speaking countries-a survey study of physicians
Michal Novotny, Jan Bulla, Daniela Hubl, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2021
Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups
Zbysek Pavelek, Michal Novotny, Ondrej Soucek, et al.
Journal of Immunology Research
|
April 17, 2023
Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor
Zbysek Pavelek, Ondrej Soucek, Jan Krejsek, et al.
Journal of Speech, Language, and Hearing Research : JSLHR
|
December 6, 2022
Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation
Jan Svihlik, Michal Novotny, Tereza Tykalova, et al.
Multiple Sclerosis and Related Disorders
|
November 18, 2017
Characteristics of motor speech phenotypes in multiple sclerosis
Jan Rusz, Barbora Benova, Hana Ruzickova, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Impact of itopride on functional dyspepsia symptom progression: a multicenter noninterventional postregistration study
Jiri Dolina, Jan Tack, Serhiy Forostyak, et al.
International Journal of Molecular Sciences
|
August 27, 2021
Neuropharmacology of Cevimeline and Muscarinic Drugs-Focus on Cognition and Neurodegeneration
Patrik Oleksak, Michal Novotny, Jiri Patocka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 11, 2023
The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease
Martin Valis, Alzbeta Dlabkova, Jakub Hort, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 29, 2023
Corrigendum to "The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease" [Biomed. Pharmacother. 159 (2023) 114223]
Martin Valis, Alzbeta Dlabkova, Jakub Hort, et al.
European Neurology
|
July 20, 2023
Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis
Marek Peterka, Martin Valis, Ondrej Soucek, et al.
Frontiers in Public Health
|
January 23, 2024
Pregabalin use in forensic hospitals and prisons in German speaking countries-a survey study of physicians
Michal Novotny, Jan Bulla, Daniela Hubl, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2021
Multiple sclerosis and immune system biomarkers: Novel comparison in glatiramer acetate and interferon beta-1a-treated patient groups
Zbysek Pavelek, Michal Novotny, Ondrej Soucek, et al.
Journal of Immunology Research
|
April 17, 2023
Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor
Zbysek Pavelek, Ondrej Soucek, Jan Krejsek, et al.
Journal of Speech, Language, and Hearing Research : JSLHR
|
December 6, 2022
Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation
Jan Svihlik, Michal Novotny, Tereza Tykalova, et al.
Multiple Sclerosis and Related Disorders
|
November 18, 2017
Characteristics of motor speech phenotypes in multiple sclerosis
Jan Rusz, Barbora Benova, Hana Ruzickova, et al.
Page
of 5